Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
about
Systematic review of influenza resistance to the neuraminidase inhibitorsImpact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental ReproducibilityProgress in Treatment of Viral Infections in Children with Acute Lymphoblastic LeukemiaClinical Implications of Antiviral Resistance in InfluenzaInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewInfluenza prevention and treatment in transplant recipients and immunocompromised hostsPathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaquesDiscovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral ResistanceProlonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferretsH1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural AnalysisStructural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA InhibitionA Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B VirusesMechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activitySynthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylateRisk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivirThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceBinding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometryTriple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virusExploring the mechanism of zanamivir resistance in a neuraminidase mutant: a molecular dynamics studyParallel screening of wild-type and drug-resistant targets for anti-resistance neuraminidase inhibitorsSimultaneous detection of oseltamivir- and amantadine-resistant influenza by oligonucleotide microarray visualizationI222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) virusesInhibition of influenza H7 hemagglutinin-mediated entryInfluenza: from zoonosis to pandemicIdentification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput ScreeningTwo years after pandemic influenza A/2009/H1N1: what have we learned?The pharmacological management of severe influenza infection - 'existing and emerging therapies'.Increased virulence of neuraminidase inhibitor-resistant pandemic H1N1 virus in mice: potential emergence of drug-resistant and virulent variantsPandemic influenza: a never-ending story.In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase.New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusionA conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance.Mutagenesis studies of the H5 influenza hemagglutinin stem loop region.Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.Influenza A H1N1pdm 2009 Virus in Paraguay: Nucleotide Point Mutations in Hemagglutinin and Neuraminidase Genes are not Associated with Drug Resistance.H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferretsNovel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysisMultidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child
P2860
Q21261835-C29EF8E1-71D1-41C5-B343-9ED2675B7860Q24288661-6314E8F9-DDC2-4373-9D4D-3C9DF62B9DB5Q26740588-32F51768-61BF-4328-A681-A5433389F25FQ26782746-F97319AD-2198-40F4-8BB2-2A8D74D219C7Q26860032-80B02093-0D8C-4458-98C2-E70C3B789CF9Q27011595-CCCE9920-ED5E-479A-A2FD-F78CB7AE8B91Q27305046-8D0DDEA7-A4F9-4986-8FD3-7802FA51C0E2Q27316994-4CA7697D-A33A-41B4-9E65-5C2AF960E063Q27334946-19358103-F76A-442A-8D68-8663D2A0AD97Q27673887-0F3E7827-5BF4-4624-B952-C20919E6CC8FQ27675230-22902D52-4C82-4816-9D1C-89643BCD4C77Q27683640-382634E4-4867-436F-9616-46731F7C0DBDQ27684054-06A6A2C6-727C-46C0-ACB1-5822133C2E1EQ27688897-DF2BE2F0-C152-4FD4-9ED8-3DCA488F440AQ28066861-775110A5-4E6D-42A3-B041-A0480DACCB27Q28071809-14C1D247-3B32-4390-AFF1-E1B67DE7168AQ28282405-1E774522-A50A-4B2A-B971-F737EF06F6C4Q28292279-C2631D20-F641-4DA1-9059-77056F60858CQ28478637-218AECC1-9691-4017-8D27-132953E6406BQ28483631-7EF569D4-B516-42CB-A597-87108EBCF19AQ28486252-D287B488-C22F-4912-A6CD-8A6A0B520FF2Q28486551-C65B3315-4BA1-4BCD-A4B9-3E599984C596Q28533778-EA46BB12-6C9D-4094-9527-90FBBD021CD0Q28534616-9077D20B-DC49-42AD-A027-DB047EE82713Q28596741-ACF38FEC-BDE2-4792-B1B9-8CBC07B2B425Q28830304-F0CB05B4-D3C0-429C-85BE-271277797E0DQ30224656-FE66C2FC-AA34-4961-9808-CE05FE31DEE6Q30243907-92874CAC-588E-4F96-91AF-9BF59C2401AFQ30352666-CC73A552-3F99-43FB-A2C8-A1EC54642A87Q30353560-90BCC7EB-5A39-4661-BFB1-AEAAA851FE84Q30353814-0F5E564C-06F9-4438-BA80-057F6A548D7FQ30355297-D7A6565A-B87B-4DCD-BEC2-796744854802Q30357193-01422BE0-8513-4F8F-B0BC-7263B75CCF49Q30363789-D72A42A2-757F-4C5A-8E60-1AD817E547ABQ30367861-259A67D5-4A2A-43B9-9848-1E076F3EB7D5Q30367931-EA083F81-1851-4C7A-AAD6-54168562973DQ30401587-EF1E5A3B-0C46-4974-8213-D0E93D0DF6FCQ30403382-7603989C-16BB-4534-9D98-53077EF134D3Q30404485-ED5DB6CA-7CD3-41A8-BE71-D3EFB63E84D6Q30405407-E416C342-2E4F-4AD9-A8D4-B7E7AE302B35
P2860
Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
@en
Emergence of a multidrug-resistant pandemic influenza A
@nl
type
label
Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
@en
Emergence of a multidrug-resistant pandemic influenza A
@nl
prefLabel
Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
@en
Emergence of a multidrug-resistant pandemic influenza A
@nl
P2093
P356
P1476
Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
@en
P2093
Charles A B Boucher
Erhard van der Vries
Foekje F Stelma
P304
P356
10.1056/NEJMC1003749
P407
P577
2010-09-01T00:00:00Z